10 Best Short Squeeze Stocks to Buy According to Analysts
Stock market trading has an ever-changing environment. Short squeeze is among the few phenomena capable of capturing and holding the attention of such markets.
Arrivent Biopharma Inc. (AVBP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hillhouse Capital Management Lei Zhang | 4,484,672 | $82,742,198 | 2.02% | |
| 2. | Suvretta Capital Management Aaron Cowen | 3,703,452 | $68,328,689 | +9% | 1.75% |
| 3. | OrbiMed Advisors Samuel Isaly | 3,027,328 | $55,854,202 | 1.31% | |
| 4. | Octagon Capital Advisors Ting Jia | 1,971,054 | $36,365,946 | +2% | 5.51% |
| 5. | Siren L.L.C. Raymond Debbane | 700,000 | $12,915,000 | 0.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 555,555 | $9,999,990.00 | 4,484,672 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing | |
| $18.00 | 222,222 | $3,999,996.00 | 1,513,664 | 2024-01-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,868,923 | $71,381,629 | 13.13% | |
| 2. | 3,407,549 | $62,869,279 | 0% | |
| 3. | 2,046,138 | $37,751,246 | 0% | |
| 4. | 2,029,531 | $37,444,847 | 0% | |
| 5. | 1,942,142 | $35,832,520 | 2.31% |
News See All
Hedge Fund Resource Center Billionaire Hedge Funds
